IDEXX LABORATORIES INC /DE Asset Impairment Charges
IDEXX LABORATORIES INC /DE (IDXX) reported Asset Impairment Charges of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE asset impairment charges for the quarter ending 2026-06-30 was $0.00.
- IDEXX LABORATORIES INC /DE asset impairment charges for the quarter ending 2026-03-31 was $5.00M.
- IDEXX LABORATORIES INC /DE asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE asset impairment charges for the quarter ending 2025-06-30 was $0.00.
- IDEXX LABORATORIES INC /DE asset impairment charges for fiscal 2024 was $250.00K, a 83.15% decline from fiscal 2023.
- IDEXX LABORATORIES INC /DE asset impairment charges for fiscal 2023 was $1.48M, a 36.74% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE asset impairment charges for fiscal 2022 was $2.35M, a 54.43% decline from fiscal 2021.
- IDEXX LABORATORIES INC /DE asset impairment charges for fiscal 2021 was $5.15M, a 105.84% increase from fiscal 2020.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.00M 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-05 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 derived: sum of 3 quarters · filed 2025-11-03 | $250.00K 10-K · filed 2025-02-21 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $250.00K 10-Q · filed 2025-11-03 | $1.73M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $250.00K 10-Q · filed 2025-08-04 | $1.73M derived: sum of 3 quarters · filed 2025-08-04 | $1.73M derived: sum of 4 quarters · filed 2025-08-04 |
| 2024-03-31 | $250.00K 10-Q · filed 2025-05-01 | $1.73M derived: sum of 2 quarters · filed 2025-05-01 | $1.73M derived: sum of 3 quarters · filed 2025-05-01 | $1.73M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $1.48M derived: sum of 2 quarters · filed 2025-02-21 | $1.48M derived: sum of 3 quarters · filed 2025-02-21 | $1.48M 10-K · filed 2025-02-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | $0.00 derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $2.35M 10-K · filed 2025-02-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.35M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $2.35M 10-Q · filed 2023-08-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.35M derived: sum of 2 quarters · filed 2024-02-22 | $5.15M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.15M 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $3.79M 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $2.50M derived: sum of 2 quarters · filed 2023-02-16 | $2.50M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.99M 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-30 | |||
| 2019-12-31 | $968.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $968.00K 10-K · filed 2022-02-16 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |